The import of tetracyclines into China is projected to grow steadily from 2024 to 2028, starting at 16.632 million USD and reaching 19.306 million USD. Compared to the 2023 data, this forecast indicates a consistent year-on-year increase from 2024 onwards. This growth represents a compound annual growth rate (CAGR) reflecting an upward trajectory in the demand for tetracyclines over this period.

Future trends to watch for include:

Potential changes in China's domestic production capabilities, which might impact import needs.
Regulatory developments that could affect both import volumes and pricing structures.
Evolution in demand due to China's healthcare policies and antibiotic use practices.